Proteus syndrome caused by novel somatic AKT1 duplication

被引:3
|
作者
AlAnzi, Talal [1 ]
Al-mashharawi, Eman [2 ]
Alhashem, Amal [3 ]
机构
[1] Prince Sultan Mil Med City, Div Med Genet, Dept Pediat, Riyadh, Saudi Arabia
[2] Prince Sultan Mil Med City, Dept Otolaryngol, Riyadh, Saudi Arabia
[3] Alfaisal Univ, Coll Med, Riyadh, Saudi Arabia
关键词
AKT1; de novo; mosaicism; Proteus; syndrome;
D O I
10.15537/smj.2021.1.25618
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Proteus syndrome (PS) is a rare overgrowth disorder that presents with asymmetrical growth of the bone and fat tissues following a mosaic pattern mutation. The estimated worldwide incidence is approximately one in one million live births. Proteus syndrome causes disfigurement and psychological impact through its effects on somatic tissue. Due to its rarity and diversity of tissues involved, it represents a significant challenge to caregivers and multidisciplinary medical teams. Here, we report a Saudi girl, with a large left cervical mass discovered antenatally. This mass was identified as a growing cystic hygroma, and she had features of overgrowth and hemangiomas. Whole exome sequencing was negative from the blood lymphocytes and affected tissue sample. However, deletion duplication analysis from tissue shows a novel mosaic somatic mutation of the AKT1 gene. Somatic mutation remains an obstacle, and the geneticist has an essential role in its management, providing an established genetic diagnosis, prognosis, and family counselling.
引用
收藏
页码:95 / 99
页数:5
相关论文
共 50 条
  • [41] High-level somatic mosaicism of AKT1 c.49G>A mutation in skin scrapings from epidermal nevi enables non-invasive molecular diagnosis in patients with Proteus syndrome
    Wieland, Ilse
    Tinschert, Sigrid
    Zenker, Martin
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2013, 161A (04) : 889 - 891
  • [42] The Mst1 kinase, an Akt1 inhibitor, is a novel regulator of the androgen receptor
    Cinar, Bekir
    Akgul, Seckin
    Mukhopadhyay, Nishit K.
    Gioeli, Daniel G.
    Freeman, Michael R.
    CANCER RESEARCH, 2009, 69
  • [43] Absence of AKT1 Mutations in Glioblastoma
    Bleeker, Fonnet E.
    Lamba, Simona
    Zanon, Carlo
    van Tilborg, Angela A.
    Leenstra, Sieger
    Troost, Dirk
    Hulsebos, Theo
    Vandertop, W. Peter
    Bardelli, Alberto
    PLOS ONE, 2009, 4 (05):
  • [44] SUMOylation regulates AKT1 activity
    de la Cruz-Herrera, C. F.
    Campagna, M.
    Lang, V.
    del Carmen Gonzalez-Santamaria, J.
    Marcos-Villar, L.
    Rodriguez, M. S.
    Vidal, A.
    Collado, M.
    Rivas, C.
    ONCOGENE, 2015, 34 (11) : 1442 - 1450
  • [45] Akt1 in endothelial cell and angiogenesis
    Somanath, Payaningal R.
    Razorenova, Olga V.
    Chen, Juhua
    Byzova, Tatiana V.
    CELL CYCLE, 2006, 5 (05) : 512 - 518
  • [46] Design, synthesis, and evaluation of novel Akt1 inhibitors based on an indole scaffold
    Yang, Dezhi
    Tong, Dongdong
    Zhang, Qian
    Wang, Yongtao
    Sun, Jing
    Zhang, Fenghe
    Zhao, Guisen
    CHEMICAL BIOLOGY & DRUG DESIGN, 2017, 90 (05) : 791 - 803
  • [47] Ropivacaine as a novel AKT1 specific inhibitor regulates the stemness of breast cancer
    Ding, Lin
    Jiang, Hui
    Li, Qiangwei
    Li, Qiushuang
    Zhang, Tian-Tian
    Shang, Limeng
    Xie, Bin
    Zhu, Yaling
    Ding, Keshuo
    Shi, Xuanming
    Zhu, Tao
    Zhu, Yong
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2024, 43 (01)
  • [48] A Novel AKT1 Mutant Amplifies an Adaptive Melanoma Response to BRAF Inhibition
    Shi, Hubing
    Hong, Aayoung
    Kong, Xiangju
    Koya, Richard C.
    Song, Chunying
    Moriceau, Gatien
    Hugo, Willy
    Yu, Clarissa C.
    Ng, Charles
    Chodon, Thinle
    Scolyer, Richard A.
    Kefford, Richard F.
    Ribas, Antoni
    Long, Georgina V.
    Lo, Roger S.
    CANCER DISCOVERY, 2014, 4 (01) : 69 - 79
  • [49] Ropivacaine as a novel AKT1 specific inhibitor regulates the stemness of breast cancer
    Lin Ding
    Hui Jiang
    Qiangwei Li
    Qiushuang Li
    Tian-Tian Zhang
    Limeng Shang
    Bin Xie
    Yaling Zhu
    Keshuo Ding
    Xuanming Shi
    Tao Zhu
    Yong Zhu
    Journal of Experimental & Clinical Cancer Research, 43
  • [50] AKT1基因嵌合性体细胞突变导致Proteus综合征临床研究
    徐杨
    傅文贞
    何进卫
    岳华
    章振林
    中华内科杂志, 2019, (07) : 508 - 513